Paracetamol Serraclinics (Paracetamol)

Paracetamol reduces pain and fever by inhibiting the synthesis of prostaglandins in the central nervous system. It acts mainly on cyclooxygenase enzymes in the brain, lowering the hypothalamic set‑point for temperature and decreasing the perception of pain without significant anti‑inflammatory activity.

The appropriate dose of Paracetamol Serraclinics is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and local treatment guidelines. Healthcare professionals adjust the dosage to achieve effective analgesia or antipyresis while staying within safe limits.

Safety data for intravenous paracetamol during pregnancy and lactation are limited. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and only under the guidance of a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Compared with oral paracetamol, the intravenous form offers faster onset of action and is useful when oral intake is not possible. Unlike non‑steroidal anti‑inflammatory drugs, it lacks significant anti‑inflammatory effects but also carries a lower risk of gastrointestinal irritation and platelet inhibition.

Paracetamol Serraclinics should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. The product should be kept in its original packaging until use to maintain stability and sterility.

The medication is given by intravenous infusion, typically diluted in a compatible solution and administered over a short period as directed by the prescriber. Administration should be performed by qualified healthcare personnel in a clinical setting, following aseptic technique and monitoring for any adverse reactions.

Serious risks include anaphylactic or severe allergic reactions, rare but potentially fatal skin conditions such as Stevens‑Johnson syndrome, and hepatotoxicity, especially when total daily paracetamol intake exceeds recommended limits or in patients with pre‑existing liver disease.

Paracetamol Serraclinics is contraindicated in individuals with known hypersensitivity to paracetamol or any component of the formulation, and should be used with extreme caution or avoided in patients with severe hepatic impairment or those who have experienced severe reactions to paracetamol previously.